Literature DB >> 29517980

Role of hypertension in progression of chronic kidney disease in children.

Smitha R Vidi1.   

Abstract

PURPOSE OF REVIEW: Hypertension is an independent risk factor for progression of chronic kidney disease (CKD) in children. Children with early CKD develop hypertension secondary to renal disease. This review aims to highlight recent advances that help us better understand the current role of hypertension in progression of CKD in children. RECENT
FINDINGS: There is increasing evidence that children with CKD who have hypertension develop early atherosclerosis and cardiac adaptive changes. Emerging data from pediatric research in CKD show that elevated blood pressure is associated with the presence of abnormal subclinical markers of cardiovascular disease including increased carotid intima-media thickness, pulse wave velocity and left ventricular mass index. There is also some evidence that these early cardiovascular changes are reversible. Twenty-four hour ambulatory blood pressure monitoring (ABPM) is recommended in children with CKD by the American Academy of Pediatrics to diagnose hypertension.
SUMMARY: Hypertension is associated with subclinical cardiovascular disease in children with CKD. Early diagnosis of hypertension by ABPM and identification of subclinical cardiovascular changes provide a window for intervention, which may reverse early cardiovascular disease, thereby delaying dialysis and improving cardiovascular morbidity and mortality.

Entities:  

Mesh:

Year:  2018        PMID: 29517980     DOI: 10.1097/MOP.0000000000000595

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  6 in total

Review 1.  Ambulatory Blood Pressure Monitoring in Pediatrics.

Authors:  Sonali S Patel; Stephen R Daniels
Journal:  Curr Hypertens Rep       Date:  2019-07-26       Impact factor: 5.369

2.  Agreement between attended home and ambulatory blood pressure measurements in adolescents with chronic kidney disease.

Authors:  Trevor W Glenn; Cyd K Eaton; Kevin J Psoter; Michelle N Eakin; Cozumel S Pruette; Kristin A Riekert; Tammy M Brady
Journal:  Pediatr Nephrol       Date:  2022-02-15       Impact factor: 3.651

3.  Effect of (-)-epicatechin on the modulation of progression markers of chronic renal damage in a 5/6 nephrectomy experimental model.

Authors:  Jorge Montes-Rivera; Mónica Arellano-Mendoza; Nayelli Nájera; Leonardo Del Valle-Mondragón; Francisco Villarreal; Ivan Rubio-Gayosso; Javier Perez-Duran; Eduardo Meaney; Guillermo Ceballos
Journal:  Heliyon       Date:  2019-04-16

4.  Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease.

Authors:  Patrícia de Carvalho Ribeiro; Fernando Henrique Lojudice; Ida Maria Maximina Fernandes-Charpiot; Maria Alice Sperto Ferreira Baptista; Stanley de Almeida Araújo; Gloria Elisa Florido Mendes; Mari Cleide Sogayar; Mario Abbud-Filho; Heloisa Cristina Caldas
Journal:  Stem Cell Res Ther       Date:  2020-12-09       Impact factor: 6.832

5.  Combined therapy of hypertensive nephropathy with ginkgo leaf extract and dipyridamole injection and antihypertensive drugs: A systematic review and meta-analysis.

Authors:  Dinala Jialiken; Lichao Qian; Shuai Ren; Lihua Wu; Junyao Xu; Chong Zou
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

6.  Identification of hypertension in hospitalized children prescribed as-needed antihypertensive medication.

Authors:  Kathryn R Kocher; Dmitry Tumin; Amber G Lehmann; Lilliana Michelle Gomez Mendez
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-04       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.